VANCOUVER, Oct. 6 /PRNewswire-FirstCall/ -- Biotech Holdings (the "Company", TSXV:BIO.V; OTC BB: BIOHF; Frankfurt: 925970.F) is pleased to announce that it held its annual meeting on September 29, 2006.
The formal business of the meeting included acceptance of the March 31, 2006 financial statements, confirmation that STS Partners LLP would continue in the coming year as auditors for the company and election of directors.
Directors elected at the Annual General Meeting were Robert Rieveley, Cheryl Rieveley, Gale Belding, Johan de Rooy, Art Cowie and Ross Wilmot. The independent (outside) directors are Art Cowie, Johan de Rooy and Ross Wilmot.
Management and directors answered questions from shareholders present at the meeting.
Following the annual meeting, the directors appointed members to an Audit Committee consisting of Ross Wilmot, Art Cowie, Robert Rieveley and Johan de Rooy (Chair of Audit Committee) as well as a Compensation Committee consisting of Art Cowie, Johan de Rooy and Ross Wilmot (Chair of Compensation Committee).
The following officers were appointed: Robert Rieveley as Chief Executive Officer of the Company, Gale Belding as Corporate Secretary and Lorne Brown, CA as Chief Financial Officer.
This release has been approved by the Board of Directors of Biotech Holdings.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed.
CONTACT: see http://www.biotechltd.com/ or contact Austin Rand at
